Results 71 to 80 of about 113,997,697 (174)

A Mutation Network Method for Transmission Analysis of Human Influenza H3N2

Viruses, 2020
Characterizing the spatial transmission pattern is critical for better surveillance and control of human influenza. Here, we propose a mutation network framework that utilizes network theory to study the transmission of human influenza H3N2. On the basis
Chi Zhang, Yinghan Wang, Cai Chen, Haoyu Long, Junbo Bai, Jinfeng Zeng, Zicheng Cao, Bing Zhang, Wei Shen, Feng Tang, Shiwen Liang, Caijun Sun, Yuelong Shu, Xiangjun Du   +13 more
doaj   +1 more source

Some Exposure for Influenza Hemagglutinin Interface Antibodies

Immunological Reviews, Volume 342, Issue 1, September 2026.
ABSTRACT Influenza viruses are a constant threat to human health. Current vaccines often confer low to moderate protection against infection with seasonal viruses and little‐to‐no protection against pandemic viruses. Improved vaccines are needed. These vaccines will need to reliably elicit antibodies to conserved sites that are broadly protective.
Kevin R. McCarthy
wiley   +1 more source

Epidemiology of Influenza Virus Types and Subtypes in South Africa, 2009–2012

Emerging Infectious Diseases, 2014
To determine clinical and epidemiologic differences between influenza caused by different virus types and subtypes, we identified patients and tested specimens.
Adam L. Cohen, Orienka Hellferscee, Marthi Pretorius, Florette Treurnicht, Sibongile Walaza, Shabir Madhi, Michelle Groome, Halima Dawood, Ebrahim Variava, Kathleen Kahn, Nicole Wolter, Anne von Gottberg, Stefano Tempia, Marietjie Venter, Cheryl Cohen   +14 more
doaj   +1 more source

What Antibody Repertoires See: Structural and Immunogenetic Insights Into Influenza A Virus Hemagglutinin Recognition

Immunological Reviews, Volume 342, Issue 1, September 2026.
ABSTRACT Human infection with or vaccination against influenza A virus has been one of the most informative systems for understanding how human antibody repertoires recognize viral glycoproteins. Decades of antibody isolation, repertoire sequencing, lineage tracing, serology, viral antigenic evolution, and structural biology have shown that antibody ...
Bruno Bonnettaz, Goran Bajic
wiley   +1 more source

Influenza and the implications of a pandemic for Malta [PDF]

, 2005
An influenza pandemic is inevitable and recent reports from Southeast Asia on avian influenza viruses infecting humans have served to fuel worries that a new pandemic is near.
Melillo Fenech, Tanya, Farrugia, Ryan, Spiteri, Gianfranco   +2 more
core  

FEATURES OF EPIDEMIC PROCESS OF INFLUENZA A(H1N1)PDM09 AND A(H3N2) IN RUSSIA FROM 2009 TO 2017

Вопросы вирусологии, 2018
The goal of this work is to compare the key parameters of influenza epidemics of different etiology. Four epidemics of influenza with predominance of influenza A(H1N1)pdm09 and 4 epidemics of influenza A(H3N2) were analyzed using the database of the ...
L. S. Karpova, K. M. Volik, K. A. Stolyarov, N. M. Popovtseva, T. P. Stolyarova, A. A. Sominina, E. I. Burtseva   +6 more
doaj   +1 more source

Influenza Vaccine Effectiveness Against Mild and Severe Outcomes: A Comparison Study in Portugal

Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
ABSTRACT Background Influenza vaccination is an effective public health intervention to lessen influenza effect on healthcare and has been recommended to prevent severe outcomes. Previous studies present higher influenza vaccine effectiveness (IVE) estimates against primary care medically attended (outpatients) compared to hospitalised cases ...
Francisco Mourao, Verónica Gómez, Patrícia Soares, Ana Paula Rodrigues, Carlos Matias Dias, Ausenda Machado   +5 more
wiley   +1 more source

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. [PDF]

, 2009
Human infections with highly pathogenic avian influenza viruses of the H5N1 subtype, frequently reported since 2003, result in high morbidity and mortality.
Sutter, G. (Gerd), Sutter Gerd, Rimmelzwaan, Guus F., Osterhaus, A.D.M.E. (Albert), Yasemin Suezer, Gerrie de Mutsert, Suezer, Yasemin, Geert van Amerongen, Löwer, Johannes, Fouchier Ron A. M., Osterhaus, Albert D. M. E., Kreijtz, Joost H. C. M., Mutsert, Gerrie de, Fouchier, Ron A. M., Fouchier, R.A.M. (Ron), Guus F Rimmelzwaan, van den Brand Judith M. A., Löwer Johannes, Johannes Löwer, Kreijtz, J.H.C.M. (Joost), Suezer, Y., Judith M A van den Brand, Suezer Yasemin, Mutsert, G. (Gerrie) de, Amerongen, G. (Geert) van, Rimmelzwaan Guus F., Brand, J.M.A. (Judith) van den, Joost H C M Kreijtz, Sutter, Gerd, Schwantes, Astrid, de Mutsert Gerrie, Brand, Judith M. A. van den, Osterhaus Albert D. M. E., Schwantes Astrid, Scwantes, A. (Astrid), Ron A M Fouchier, van Amerongen Geert, Albert D M E Osterhaus, Gerd Sutter, Astrid Schwantes, Rimmelzwaan, G.F. (Guus), Kreijtz Joost H. C. M., Amerongen, Geert van, Löwer, J., Fouchier, Ron A.M.; id_orcid, Scwantes, Astrid, van Amerongen, Geert, van den Brand, Judith M.A., Osterhaus, Albert D.M.E., Kreijtz, Joost H.C.M., de Mutsert, Gerrie   +50 more
core   +1 more source

Influenza vaccine effectiveness against hospitalizations associated with influenza a in Hong Kong children aged 9 months to 17 years, 2024/25

Vaccine: X
Influenza began circulating in Hong Kong in mid-December 2024. As of 12 March 2025, 1279 children were enrolled in a prospective test negative study for influenza vaccine effectiveness (VE). Among 209 influenza-positive cases, 71 % had influenza A(H1N1),
Caitriona Murphy, Mike Y.W. Kwan, Eunice L.Y. Chan, Joshua S.C. Wong, Sheena G. Sullivan, Malik Peiris, Benjamin J. Cowling, So-Lun Lee   +7 more
doaj   +1 more source

Influenza Vaccination Effectiveness in Preventing Hospitalization of Adults With Underlying Medical Conditions: A Multicentre Case–Control Study

Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
ABSTRACT Background Seasonal influenza, especially in persons with underlying medical conditions, is a substantial global burden. Influenza vaccination effectiveness (VE) varies annually, requiring continuous evaluation due to evolving viruses and vaccination coverages. Our aim was to investigate influenza VE in preventing hospitalization for confirmed
Diana Toledo, Núria Soldevila, Juan Carlos Galan, Pere Godoy, María Morales‐Suarez‐Varela, Marta Rodriguez‐Suárez, María Grau, Tania Fernández‐Villa, Aurea Morillo, Gemma Navarro, Judith Chamorro, Angela Domínguez, Project PI19/00354 Working Group, Raquel Valencia, María Amelia Fernández‐Sierra, María Mar Rodríguez, José Antonio Marín, Gerardo Rubiera, Vicente Martín, Graciela López‐Muñiz, Carmen Fernández Martínez de Septien, Silvia Fernández, Núria Torner, Carles Vilaplana, Lluís Forcadell, Cristina Rius, Anna Vilella, Silvia Simó‐Nebot, Eva del Amo, Magda Campins, Xavier Martínez, José Angel Rodrigo, Judith Martínez, Ramon Boixeda, Julia Jaumandreu, Jenaro Astray, Concepción Prados‐Sánchez, Alberto Mangas‐Moro, Amaranta McGee‐Laso, Laura Moreno‐Galarraga, Nerea Díaz‐Sánchez, Idaira Fernandez‐Rodriguez, Cristina Llonch, Itziar Casado, Fernando Baigorria‐Feltrin, Alba Gasque, Sara Marquínez‐Noriega, Mikel Egurrola‐Izquierdo, Patricia García, Isabel Peraita‐Costa, Francisco Sanz   +50 more
wiley   +1 more source